Global Biosynthesis of Cannabinoids Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Biosynthesis of Cannabinoids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biosynthesis of Cannabinoids market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global key companies of Biosynthesis of Cannabinoids include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, and Librede, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosynthesis of Cannabinoids market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
THC
CBD
Others
Market segment by Application, can be divided into
Food Industry
Medical Industry
Others
Market segment by players, this report covers
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Market segment by regions, regional analysis covers
North America
Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
South America
Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Biosynthesis of Cannabinoids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosynthesis of Cannabinoids, with recent developments and future plans
Chapter 3, the Biosynthesis of Cannabinoids competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Biosynthesis of Cannabinoids market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe Biosynthesis of Cannabinoids research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biosynthesis of Cannabinoids
1.2 Classification of Biosynthesis of Cannabinoids by Type
1.2.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Type: 2022 Versus 2028
1.2.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Type in 2028
1.2.3 THC
1.2.4 CBD
1.2.5 Others
1.3 Global Biosynthesis of Cannabinoids Market by Application
1.3.1 Overview: Global Biosynthesis of Cannabinoids Market Size by Application: 2022 Versus 2028
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Global Biosynthesis of Cannabinoids Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
1.5.1 Biosynthesis of Cannabinoids Market Drivers
1.5.2 Biosynthesis of Cannabinoids Market Restraints
1.5.3 Biosynthesis of Cannabinoids Trends Analysis
2 Company Profiles
2.1 Anandia Laboratories
2.1.1 Anandia Laboratories Details
2.1.2 Anandia Laboratories Major Business
2.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Product and Solutions
2.1.4 Anandia Laboratories Recent Developments and Future Plans
2.2 Gingko Bioworks
2.2.1 Gingko Bioworks Details
2.2.2 Gingko Bioworks Major Business
2.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Product and Solutions
2.2.4 Gingko Bioworks Recent Developments and Future Plans
2.3 Hyasynth Bio
2.3.1 Hyasynth Bio Details
2.3.2 Hyasynth Bio Major Business
2.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Product and Solutions
2.3.4 Hyasynth Bio Recent Developments and Future Plans
2.4 InMed Pharmaceuticals
2.4.1 InMed Pharmaceuticals Details
2.4.2 InMed Pharmaceuticals Major Business
2.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
2.4.4 InMed Pharmaceuticals Recent Developments and Future Plans
2.5 Librede
2.5.1 Librede Details
2.5.2 Librede Major Business
2.5.3 Librede Biosynthesis of Cannabinoids Product and Solutions
2.5.4 Librede Recent Developments and Future Plans
2.6 Renew Biopharma
2.6.1 Renew Biopharma Details
2.6.2 Renew Biopharma Major Business
2.6.3 Renew Biopharma Biosynthesis of Cannabinoids Product and Solutions
2.6.4 Renew Biopharma Recent Developments and Future Plans
2.7 Cronos Group
2.7.1 Cronos Group Details
2.7.2 Cronos Group Major Business
2.7.3 Cronos Group Biosynthesis of Cannabinoids Product and Solutions
2.7.4 Cronos Group Recent Developments and Future Plans
2.8 Organigram
2.8.1 Organigram Details
2.8.2 Organigram Major Business
2.8.3 Organigram Biosynthesis of Cannabinoids Product and Solutions
2.8.4 Organigram Recent Developments and Future Plans
2.9 Teewinot Life Sciences
2.9.1 Teewinot Life Sciences Details
2.9.2 Teewinot Life Sciences Major Business
2.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Product and Solutions
2.9.4 Teewinot Life Sciences Recent Developments and Future Plans
2.10 ICC International Cannabis Corp.
2.10.1 ICC International Cannabis Corp. Details
2.10.2 ICC International Cannabis Corp. Major Business
2.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product and Solutions
2.10.4 ICC International Cannabis Corp. Recent Developments and Future Plans
2.11 Biotii Technologies Corp.
2.11.1 Biotii Technologies Corp. Details
2.11.2 Biotii Technologies Corp. Major Business
2.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Product and Solutions
2.11.4 Biotii Technologies Corp. Recent Developments and Future Plans
2.12 Bristol-Myers Squibb
2.12.1 Bristol-Myers Squibb Details
2.12.2 Bristol-Myers Squibb Major Business
2.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Product and Solutions
2.12.4 Bristol-Myers Squibb Recent Developments and Future Plans
2.13 Biogen Inc.
2.13.1 Biogen Inc. Details
2.13.2 Biogen Inc. Major Business
2.13.3 Biogen Inc. Biosynthesis of Cannabinoids Product and Solutions
2.13.4 Biogen Inc. Recent Developments and Future Plans
2.14 GW Pharmaceuticals
2.14.1 GW Pharmaceuticals Details
2.14.2 GW Pharmaceuticals Major Business
2.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
2.14.4 GW Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosynthesis of Cannabinoids Revenue and Share by Players (2022 & 2028)
3.2 Biosynthesis of Cannabinoids Players Head Office, Products and Services Provided
3.3 Biosynthesis of Cannabinoids Mergers & Acquisitions
3.4 Biosynthesis of Cannabinoids New Entrants and Expansion Plans
4 Global Biosynthesis of Cannabinoids Forecast by Region
4.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2022 VS 2028
4.2 Global Biosynthesis of Cannabinoids Market Size by Region, (2022-2028)
4.3 North America
4.3.1 Key Companies of Biosynthesis of Cannabinoids in North America
4.3.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in North America
4.3.3 North America Biosynthesis of Cannabinoids Market Size and Prospect (2022-2028)
4.4 Europe
4.4.1 Key Companies of Biosynthesis of Cannabinoids in Europe
4.4.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Europe
4.4.3 Europe Biosynthesis of Cannabinoids Market Size and Prospect (2022-2028)
4.5 Asia-Pacific
4.5.1 Key Companies of Biosynthesis of Cannabinoids in Asia-Pacific
4.5.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Asia-Pacific
4.5.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size and Prospect (2022-2028)
4.6 South America
4.6.1 Key Companies of Biosynthesis of Cannabinoids in South America
4.6.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in South America
4.6.3 South America Biosynthesis of Cannabinoids Market Size and Prospect (2022-2028)
4.7 Middle East & Africa
4.7.1 Key Companies of Biosynthesis of Cannabinoids in Middle East & Africa
4.7.2 Current Situation and Forecast of Biosynthesis of Cannabinoids in Middle East & Africa
4.7.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
5.1 Global Biosynthesis of Cannabinoids Market Forecast by Type (2022-2028)
5.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
6.1 Global Biosynthesis of Cannabinoids Market Forecast by Application (2022-2028)
6.2 Global Biosynthesis of Cannabinoids Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer
List of Tables
Table 1. Global Biosynthesis of Cannabinoids Revenue by Type, (USD Million), 2022 VS 2028
Table 2. Global Biosynthesis of Cannabinoids Revenue by Application, (USD Million), 2022 VS 2028
Table 3. Anandia Laboratories Corporate Information, Head Office, and Major Competitors
Table 4. Anandia Laboratories Major Business
Table 5. Anandia Laboratories Biosynthesis of Cannabinoids Product and Solutions
Table 6. Gingko Bioworks Corporate Information, Head Office, and Major Competitors
Table 7. Gingko Bioworks Major Business
Table 8. Gingko Bioworks Biosynthesis of Cannabinoids Product and Solutions
Table 9. Hyasynth Bio Corporate Information, Head Office, and Major Competitors
Table 10. Hyasynth Bio Major Business
Table 11. Hyasynth Bio Biosynthesis of Cannabinoids Product and Solutions
Table 12. InMed Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 13. InMed Pharmaceuticals Major Business
Table 14. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
Table 15. Librede Corporate Information, Head Office, and Major Competitors
Table 16. Librede Major Business
Table 17. Librede Biosynthesis of Cannabinoids Product and Solutions
Table 18. Renew Biopharma Corporate Information, Head Office, and Major Competitors
Table 19. Renew Biopharma Major Business
Table 20. Renew Biopharma Biosynthesis of Cannabinoids Product and Solutions
Table 21. Cronos Group Corporate Information, Head Office, and Major Competitors
Table 22. Cronos Group Major Business
Table 23. Cronos Group Biosynthesis of Cannabinoids Product and Solutions
Table 24. Organigram Corporate Information, Head Office, and Major Competitors
Table 25. Organigram Major Business
Table 26. Organigram Biosynthesis of Cannabinoids Product and Solutions
Table 27. Teewinot Life Sciences Corporate Information, Head Office, and Major Competitors
Table 28. Teewinot Life Sciences Major Business
Table 29. Teewinot Life Sciences Biosynthesis of Cannabinoids Product and Solutions
Table 30. ICC International Cannabis Corp. Corporate Information, Head Office, and Major Competitors
Table 31. ICC International Cannabis Corp. Major Business
Table 32. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product and Solutions
Table 33. Biotii Technologies Corp. Corporate Information, Head Office, and Major Competitors
Table 34. Biotii Technologies Corp. Major Business
Table 35. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product and Solutions
Table 36. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 37. Bristol-Myers Squibb Major Business
Table 38. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product and Solutions
Table 39. Biogen Inc. Corporate Information, Head Office, and Major Competitors
Table 40. Biogen Inc. Major Business
Table 41. Biogen Inc. Biosynthesis of Cannabinoids Product and Solutions
Table 42. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. GW Pharmaceuticals Major Business
Table 44. GW Pharmaceuticals Biosynthesis of Cannabinoids Product and Solutions
Table 45. Global Biosynthesis of Cannabinoids Revenue (USD Million) by Players (2022 & 2028)
Table 46. Global Biosynthesis of Cannabinoids Revenue Share by Players (2022 & 2028)
Table 47. Biosynthesis of Cannabinoids Players Head Office, Products and Services Provided
Table 48. Biosynthesis of Cannabinoids Mergers & Acquisitions in the Past Five Years
Table 49. Biosynthesis of Cannabinoids New Entrants and Expansion Plans
Table 50. Global Market Biosynthesis of Cannabinoids Revenue (USD Million) Comparison by Region (2022 VS 2028)
Table 51. Global Biosynthesis of Cannabinoids Revenue Market Share by Region (2022-2028)
Table 52. Key Companies of Biosynthesis of Cannabinoids in North America
Table 53. Current Situation and Forecast of Biosynthesis of Cannabinoids in North America
Table 54. Key Companies of Biosynthesis of Cannabinoids in Europe
Table 55. Current Situation and Forecast of Biosynthesis of Cannabinoids in Europe
Table 56. Key Companies of Biosynthesis of Cannabinoids in Asia-Pacific
Table 57. Current Situation and Forecast of Biosynthesis of Cannabinoids in Asia-Pacific
Table 58. Key Companies of Biosynthesis of Cannabinoids in China
Table 59. Key Companies of Biosynthesis of Cannabinoids in Japan
Table 60. Key Companies of Biosynthesis of Cannabinoids in South Korea
Table 61. Key Companies of Biosynthesis of Cannabinoids in South America
Table 62. Current Situation and Forecast of Biosynthesis of Cannabinoids in South America
Table 63. Key Companies of Biosynthesis of Cannabinoids in Middle East & Africa
Table 64. Current Situation and Forecast of Biosynthesis of Cannabinoids in Middle East & Africa
Table 65. Global Biosynthesis of Cannabinoids Revenue Forecast by Type (2022-2028)
Table 66. Global Biosynthesis of Cannabinoids Revenue Forecast by Application (2022-2028)
List of Figures
Figure 1. Biosynthesis of Cannabinoids Picture
Figure 2. Global Biosynthesis of Cannabinoids Revenue Market Share by Type in 2028
Figure 3. THC
Figure 4. CBD
Figure 5. Others
Figure 6. Biosynthesis of Cannabinoids Revenue Market Share by Application in 2028
Figure 7. Food Industry Picture
Figure 8. Medical Industry Picture
Figure 9. Others Picture
Figure 10. Global Biosynthesis of Cannabinoids Market Size, (USD Million): 2022 VS 2028
Figure 11. Global Biosynthesis of Cannabinoids Revenue and Forecast (2022-2028) & (USD Million)
Figure 12. Biosynthesis of Cannabinoids Market Drivers
Figure 13. Biosynthesis of Cannabinoids Market Restraints
Figure 14. Biosynthesis of Cannabinoids Market Trends
Figure 15. Anandia Laboratories Recent Developments and Future Plans
Figure 16. Gingko Bioworks Recent Developments and Future Plans
Figure 17. Hyasynth Bio Recent Developments and Future Plans
Figure 18. InMed Pharmaceuticals Recent Developments and Future Plans
Figure 19. Librede Recent Developments and Future Plans
Figure 20. Renew Biopharma Recent Developments and Future Plans
Figure 21. Cronos Group Recent Developments and Future Plans
Figure 22. Organigram Recent Developments and Future Plans
Figure 23. Teewinot Life Sciences Recent Developments and Future Plans
Figure 24. ICC International Cannabis Corp. Recent Developments and Future Plans
Figure 25. Biotii Technologies Corp. Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 27. Biogen Inc. Recent Developments and Future Plans
Figure 28. GW Pharmaceuticals Recent Developments and Future Plans
Figure 29. Global Biosynthesis of Cannabinoids Revenue Market Share by Region (2022-2028)
Figure 30. Global Biosynthesis of Cannabinoids Revenue Market Share by Region in 2028
Figure 31. North America Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2022-2028)
Figure 32. Europe Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2022-2028)
Figure 33. Asia-Pacific Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2022-2028)
Figure 34. South America Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2022-2028)
Figure 35. Middle East & Africa Biosynthesis of Cannabinoids Revenue (USD Million) and Growth Rate (2022-2028)
Figure 36. Global Biosynthesis of Cannabinoids Market Share Forecast by Type (2022-2028)
Figure 37. Global Biosynthesis of Cannabinoids Market Share Forecast by Application (2022-2028)
Figure 38. Methodology
Figure 39. Research Process and Data Source
